tiprankstipranks

Andrew D. Goldberg Insider Profile

4 Followers
Andrew D. Goldberg, Director at Tarsus Pharmaceuticals, holds 6.35K shares in Tarsus Pharmaceuticals (Ticker: TARS).
tipranks
Andrew D. Goldberg

Andrew D. Goldberg
Tarsus Pharmaceuticals (TARS)
Director

Not Ranked
Andrew D. Goldberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$296K
100.00%
A breakdown of Andrew D. Goldberg's holdings

Insider Roles

Tarsus Pharmaceuticals
(TARS)
Director
Roles that Andrew D. Goldberg holds in companies

Most Profitable Insider Trade

Stock:
Tarsus Pharmaceuticals
(TARS)
Rating:Informative Buy
Date:Dec 19, 2023 - Today
Return:+158.00%
The most profitable trade made by Andrew D. Goldberg

Andrew D. Goldberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tarsus Pharmaceuticals
Jun 25, 2024
Director
Uninformative Buy
88.56K
$295.78K
Success Rate for
TARS
1 out of 1 profitable transactions on
TARS
100%
Average Return for
TARS
Average return per transaction on
TARS
+158.00%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 19, 2023
Informative Buy
$18.96K
-
$18.96
+158.00%
Jun 25, 2024
Uninformative Buy
$88.56K
-
$26.43
Jun 21, 2023
Uninformative Buy
$37.02K
-
$18.51
List of latest transactions for each holding click on a transaction to see Andrew D. Goldberg's performance on stock

Andrew D. Goldberg insider profile FAQ

What is the percentage of profitable transactions made by Andrew D. Goldberg?
The percentage of profitable transactions made by Andrew D. Goldberg is ―.
    What is the average return per transaction made by Andrew D. Goldberg?
    The average return per transaction made by Andrew D. Goldberg is ―.
      What stocks does Andrew D. Goldberg hold?
      Andrew D. Goldberg holds: TARS stocks.
        What was Andrew D. Goldberg’s latest transaction?
        Andrew D. Goldberg latest transaction was an Uninformative Buy of $88.56K.
          What was Andrew D. Goldberg's most profitable transaction?
          Andrew D. Goldberg’s most profitable transaction was an Informative Buy of TARS stock on December 19, 2023. The return on the trade was 158.00%.
            What is Andrew D. Goldberg's role in Tarsus Pharmaceuticals?
            Andrew D. Goldberg's role in Tarsus Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.